Sartorius
Pharmaceutical and laboratory equipment supplier.
Hybrid
Some members of the team work remotely, while others are co-located in one or more offices.
👥10,000+
📍Göttingen, Niedersachsen, Germany
Sartorius

About Sartorius

About Sartorius
About Sartorius
About Sartorius
About Sartorius
About Sartorius
Sartorius Group is a leading international partner of life science research and the biopharmaceutical industry, listed on the German MDAX and TecDAX stock markets.

What Sartorius is building

Sartorius product / service
Sartorius product / service
Sartorius product / service
Sartorius product / service
Sartorius product / service
Sartorius provides bioprocess development, engineering, media, instrument, validation, octet and support services.

Technologies used at Sartorius

Front-end (2)
Back-end (2)
Android (1)
iOS (1)
ReactReact
JavascriptJavascript

Company culture

Sustainability

Growing profitably and acting responsibly towards all stakeholders

Openness

Driving change and progress internally and externally

See more

Funding roundsIconOpenNewWindows

Company type

Company type

For Profit

Sartorius news and updates

Americaninstrument partners with Sartorius

American Instrument Exchange is proud to partner with Sartorius in offering 5 models from their Entris II line of analytical balances.

Dec 12, 2022 | americaninstrument.info

IAMIP Sverige AB. partners with Sartorius

In collaboration with multinational biotech company Sartorius, IamIP unveils its latest product, the “Smart Monitoring” tool.

Dec 5, 2022 | iamip.com

Sartorius launches SUB systems such as BIOSTAT STR Generation 3 Single-Use Bioreactor, BIOSTAT RM TX Single-Use Bioreactor, and BIOSTAT STR

During the past three years, Sartorius Stedim Biotech launched SUB systems such as BIOSTAT STR Generation 3 Single-Use Bioreactor, BIOSTAT RM TX Single-Use Bioreactor, and BIOSTAT STR.

Oct 11, 2022 | selfposts.com

Sartorius partners with Incheon

Sartorius has signed a land purchase agreement with the Incheon Free Economic Zone Authority (IFEZ) as it preps to bring its biomanufacturing portfolio to the robust Korean market.

Oct 10, 2022 | bioprocessintl.com

Sartorius invests into assets : Center of Excellence in the amount of $60M in Ann Arbor, Michigan, United States

Sartorius is constructing the $60 million Center of Excellence for BioAnalytics in Ann Arbor, Mich.

Sep 12, 2022 | tradelineinc.com

Sartorius expanded facilities to China on Sep 1st 21'.

In September 2021, Sartorius AG expanded its manufacturing facilities in China in biological drug discovery, process development, testing, and validation to meet growing local customer demand.

Aug 23, 2022 | healthcare-digital.com

Sartorius is developing cell lines needed for type B vaccines and other recombinant protein vaccines

Sartorius supports customers to commercially produce the cell lines needed for type B vaccines and other recombinant protein vaccines.

Jul 27, 2022 | sartorius.com

Sartorius expanded facilities to Tunisia on May 19th 22'.

Sartorius, an international partner of life science research and the biopharmaceutical industry, is further growing its global production capacity with the expansion of its manufacturing site in Tunisia.

May 19, 2022 | contractpharma.com

Sartorius AG launches Annual Financial Report

Sartorius Stedim Biotech, a leading partner of the biopharma industry, today has presented its Universal Registration Document 2021 including the Annual Financial Report.

Jan 1, 2022 | prnewswire.com

Sartorius launched ambr 250 HT perfusion bioreactor system on Mar 1st 18'.

March 2018 : Sartorius AG unveiled an ambr 250 HT perfusion bioreactor system for cell culture process development.

Jan 1, 2022 | globenewswire.com

Sartorius acquired Maravai and Kirkland & Ellis LLP for $11B on Feb 22nd 22'.

According to media reports, Sartorius is looking to buy Maravai LifeSciences.

Jan 1, 2022 | bioprocessintl.com

Sartorius acquired Cellcare Lab on Dec 1st 16'.

For instance, in December 2016, Sartorius GmbH acquired cell line contractor Cellca.

Jan 1, 2022 | 4yo.us

Sartorius identified as competitor of Merck KGaA on Apr 20th 21'.

Sartorius, which competes in bioreactor gear with Merck KGaA and Thermo Fisher, said underlying earnings before interest, taxes, depreciation and amortisation (EBITDA) had increased by nearly a third from the same quarter last year to reach 349 million euros ($378.28 million).

Jan 1, 2022 | yahoo.com

Matica Bio partners with Sartorius

The company said that Matica Biotechnology is currently working with international pharmaceutical and laboratory equipment supplier Sartorius to develop advanced viral vector manufacturing technologies for mass production of viral vectors.

Jan 1, 2022 | koreaherald.com

Sartorius increases headcount by 160

According to Ann Arbor SPARK, an economic development agency, Sartorius’s expansion is projected to create 160 high-paying jobs.

Jan 1, 2022 | michigandaily.com

Dow Inc. partners with Sartorius

Meanwhile, Dow and Südpack Medica joined forces with life science research and biopharmaceutical company Sartorius to support the global COVID-19 vaccination fight by manufacturing bioprocessing bags, which they say are essential for the production and transportation of vaccines.

Jan 1, 2022 | packaginginsights.com

Sartorius partnered with Insat on May 27th 22'.

At the end of their internship, nearly half of them join Sartorius Tunisia permanently - a sustainable approach to attract talent and reason for the company to extend its collaborations with institutes and school: Recently, Sartorius signed a partnership agreement with the National Institute of Applied Sciences and Technology (INSAT) in Tunis.

Jan 1, 2022 | sartorius.com

Sartorius acquires Albumedix Ltd.

By acquiring Albumedix, Sartorius will be able to offer science-enabled solutions for the whole value chain of advanced therapy by adding complementary technologies and synergistic competencies to their solution space.

Jan 1, 2022 | siliconcanals.com

High Throughput Process Development Market Size, Growth and Key Players – Danaher Corporation, Ge Healthcare, Agilent Technologies, Merck Millipore, Thermo Fisher Scientific, Bio-rad Laboratories, Eppendorf Ag, Perkinelmer, Sartorius Stedim Biotech, Tecan Group Ltd.

The High Throughput Process Development Market report offers high-quality information on key market trends, product types and their scope, competitive landscape, and impact of the COVID-19 outbreak.

Sep 26, 2021 | StillWater Current

Is Sartorius Stedim Biotech S.A.'s(EPA:DIM) Recent Stock Performance Tethered To Its Strong Fundamentals?

Sartorius Stedim Biotech's (EPA:DIM) stock is up by a considerable 39% over the past three months.

Sep 16, 2021 | Simply Wall St

Sartorius expands offices in Slovenia

Slovenia: An expanded production site for market-leading... Sartorius is expanding its production capabilities in Slovenia with an extended area for manufacturing and labs in Ajdovscina.

Jan 1, 2021 | sartorius.com

TC TECH Sweden AB partners with Sartorius

TC Tech originally partnered with Sartorius, but was then acquired by Thermo Fisher Scientific, with the brand eventually being phased out.

Jan 1, 2021 | qosina.com

Sartorius launched BIOSTAT STR Generation 3 single-use bioreactor on Mar 9th 20'.

On March 9, 2020, Sartorius announced the launch of its BIOSTAT STR Generation 3 single-use bioreactor with BIOBRAIN automation platform for biopharmaceutical process development and manufacturing.

Jan 1, 2020 | pharmtech.com

Sartorius launches next generation BIOSTAT STR

Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry, announced the launch of its next generation BIOSTAT STR®, a fully scalable, single-use bioreactor family based on a conventional stirred-tank design.

Jan 1, 2017 | b3cnewswire.com

Single Use Assemblies Market By Major key Players Sartorius Stedim Biotech (France), Thermo Fisher Scientific (US), Danaher (US)

Global Market Vision has recently added a new informative report, titled “Global Single Use Assemblies market” to its ever-expanding database. The Single Use Assemblies market is analyzed with an aim to provide assistance to the readers to gain maximum returns on the investment and to enable an informed decision-making process. The report is furnished with the latest updates about the current market scenario with regards to the COVID-19 pandemic.

Jan 1, 1970 | Global Banking & Finance Review
See More